Investors seeking direct access to emerging life sciences companies will have an opportunity on September 17, 2026, when the Life Sciences Virtual Investor Forum takes place online. Hosted by Virtual Investor Conferences and presented as a B2i Digital Featured Conference, the event will feature seven companies presenting live in 30-minute sessions, each followed by audience Q&A. Replays will be available on demand via the B2i Digital and OTC Markets YouTube channels.
The forum's lineup spans a diverse range of therapeutic and diagnostic technologies. Sona Nanotech Inc. will present a photothermal cancer therapy built on gold nanorods. Raphael Pharmaceutical will discuss cannabinoid-based formulations in development for rheumatoid arthritis, chronic lung inflammation, and autoimmune disease. Amplia Therapeutics Ltd. will highlight its pipeline of Focal Adhesion Kinase inhibitors for cancer and fibrosis. Adaptin Bio, Inc. will showcase precision drug delivery technologies aimed at target tissues, including behind the blood-brain barrier. Acurx Pharmaceuticals, Inc. will present a new class of antibiotics in development for infections caused by bacteria listed as priority pathogens. CytoDyn Inc. will discuss a humanized monoclonal antibody being studied in solid-tumor oncology. 4DMedical Ltd. will feature FDA-cleared four-dimensional respiratory imaging.
The event is scheduled as follows: 11:00 AM ET Sona Nanotech Inc.; 11:30 AM ET Raphael Pharmaceutical; 2:00 PM ET Amplia Therapeutics Ltd.; 2:30 PM ET Adaptin Bio, Inc.; 3:00 PM ET Acurx Pharmaceuticals, Inc.; 3:30 PM ET CytoDyn Inc.; and 4:00 PM ET 4DMedical Ltd. All times are subject to change.
David Shapiro, Chief Executive Officer of B2i Digital, Inc., emphasized the value of live interaction. "Reading company filings is a great cure for insomnia, but if you want to stay awake and hear it directly from management, these conferences are the best way to get a real feel for the company. My favorite part is the Q&A and hearing how they handle the impromptu questions that are really on your mind," Shapiro said.
Virtual Investor Conferences, an OTC Markets Group Inc. property, regularly features public companies from exchanges worldwide, including NYSE, Nasdaq, TSX, TSXV, CSE, ASX, LSE, and the OTC Markets. The forum provides an interactive platform for companies to meet directly with investors online, offering efficient access to a broad investor audience through live presentations, Q&A sessions, and one-on-one meetings.
For investors, the event offers a chance to hear directly from management teams about pipeline progress and strategic priorities. The focus on areas such as oncology, fibrosis, drug delivery, antibiotics, cannabinoid therapeutics, and respiratory imaging reflects ongoing innovation in life sciences. Companies in these sectors often face high research and development costs and regulatory hurdles, making investor engagement critical for funding and growth.
Event details and presenting company profiles are available at https://b2idigital.com/sept-17-life-sciences-virtual-investor-forum. Registration can be completed at https://www.virtualinvestorconferences.com/wcc/eh/4814904/category/150412/september-17th-life-sciences-virtual-investor-forum?utm_source=b2i&utm_medium=marketing&utm_campaign=0917SeptLifeScienceVIC.
B2i Digital, Inc. serves as the Official Marketing Partner for the forum, leveraging its media network of over 800 news, broadcast, and trade outlets with a combined monthly audience exceeding 330 million, plus more than 1.7 million followers, 70,000 opt-in email subscribers, and a rolodex of over 235,000 capital markets contacts. The company is headquartered in New York City. More information about B2i Digital's Featured Companies, Featured Experts, and upcoming Featured Conferences can be found at https://b2idigital.com.
As life sciences companies continue to advance novel therapies and diagnostics, forums like this provide a platform for investors to assess opportunities and for companies to gain visibility. The live Q&A format allows investors to ask candid questions, potentially uncovering insights not readily available in written disclosures. With replays available, the event also accommodates those unable to attend in real time.
